We demonstrate that binding of different IgE molecules (IgEs) to their receptor, FcRI, induces a spectrum of activation events in the absence of a specific antigen and provide evidence that such activation reflects aggregation of FcRI. Highly cytokinergic IgEs can efficiently induce production of cytokines and render mast cells resistant to apoptosis in an autocrine fashion, whereas poorly cytokinergic IgEs induce these effects inefficiently. Highly cytokinergic IgEs seem to induce more extensive FcRI aggregation than do poorly cytokinergic IgEs, which leads to stronger mast cell activation and survival effects. These effects of both types of IgEs require Syk tyrosine kinase and can be inhibited by FcRI disaggregation with monovalent hapten. In hybridoma-transplanted mice, mucosal mast cell numbers correlate with serum IgE levels. Therefore, survival effects of IgE could contribute to the pathogenesis of allergic disease. M ast cells are major effector cells for immediate hypersensitivity and allergic diseases. Cross-linking of IgE bound to its high-affinity receptor, FcRI, with multivalent antigen initiates the activation of mast cells by promoting the aggregation of FcRI (1, 2). This FcRI-dependent activation results in degranulation (secretion of preformed mediators that are stored in the cytoplasmic granules, such as vasoactive amines, neutral proteases, proteoglycans, etc.), the de novo synthesis of proinflammatory lipid mediators, and the synthesis and secretion of cytokines and chemokines. In addition to these IgE͞antigen-induced activation events, IgE binding to FcRI in the absence of a specific antigen induces the up-regulation of FcRI surface expression in mast cells and basophils (3, 4) and the prolonged survival of mouse mast cells under growth factor-limiting conditions (5, 6). The enhanced surface expression of FcRI by IgE has been shown to be caused by the stabilization and accumulation of FcRI on the mast cell surface in the presence of continued basal levels of protein synthesis (7, 8) .
M
ast cells are major effector cells for immediate hypersensitivity and allergic diseases. Cross-linking of IgE bound to its high-affinity receptor, FcRI, with multivalent antigen initiates the activation of mast cells by promoting the aggregation of FcRI (1, 2) . This FcRI-dependent activation results in degranulation (secretion of preformed mediators that are stored in the cytoplasmic granules, such as vasoactive amines, neutral proteases, proteoglycans, etc.), the de novo synthesis of proinflammatory lipid mediators, and the synthesis and secretion of cytokines and chemokines. In addition to these IgE͞antigen-induced activation events, IgE binding to FcRI in the absence of a specific antigen induces the up-regulation of FcRI surface expression in mast cells and basophils (3, 4) and the prolonged survival of mouse mast cells under growth factor-limiting conditions (5, 6) . The enhanced surface expression of FcRI by IgE has been shown to be caused by the stabilization and accumulation of FcRI on the mast cell surface in the presence of continued basal levels of protein synthesis (7, 8) .
Two studies on the survival effect of monomeric IgE (5, 6) suggest differences in the potential mechanisms: Kalesnikoff et al. (6) found that IgE binding induces secretion of a variety of cytokines that enhance cell survival by an autocrine mechanism.
In support of this model, they also found tyrosine phosphorylation of the FcRI ␤ subunit and activation of Akt and mitogen-activated protein kinases (MAPKs) in IgE-treated mast cells. In contrast, Asai et al. (5) did not detect significant cytokine secretion or any signaling events, which are known to be elicited by IgE͞antigen-induced FcRI aggregation (9, 10) , in IgEtreated mast cells (5) .
We have addressed why the two studies detected different antiapoptotic mechanisms, and we have performed experiments to elucidate further the mechanisms responsible for these effects. Our results demonstrate that all of the various IgE molecules (IgEs) tested showed antiapoptotic effects on mast cells, but that the different IgEs exhibited a wide spectrum in their ability to induce the production and secretion of cytokines by mast cells. At one extreme, the most highly cytokinergic (HC) IgEs can induce strong antiapoptotic effects, in part by an autocrine mechanism. At the other end of the spectrum, poorly cytokinergic (PC) IgEs induce less robust survival effects, but without inducing detectable cytokine production. Importantly, several lines of evidence indicate that binding of either HC or PC IgEs can result in FcRI aggregation in the absence of the antigen for which that IgE is known to have specificity, with more extensive FcRI aggregation induced by HC than by PC IgEs. Furthermore, mast cell numbers were increased in some gastrointestinal mucosal tissues of mice harboring IgE-secreting hybridoma, consistent with a ''survival effect'' of high serum IgE levels.
Materials and Methods
IgE Preparations. Anti-dinitrophenyl (DNP) mouse IgE monoclonal antibodies [H1 DNP--206 and H1 DNP--26 (11)] were purified as described previously (12) . Briefly, ascites recovered from CAF1͞J mice harboring the IgE hybridoma were fractionated by ammonium sulfate precipitation. IgE-containing fractions were further purified by DEAE column chromatography.
knockout (15) , and lyn knockout (16) mice were cultured in IL-3-containing medium for 4-6 weeks to generate Ͼ95% pure populations of bone marrow-derived cultured mast cells (BMCMC). Syk Ϫ/Ϫ BMCMC were generated from bone marrow cells of sublethally irradiated mice that had been reconstituted with syk Ϫ/Ϫ fetal liver cells (17) . Cells were incubated with various concentrations of IgE for the indicated periods. For FcRI cross-linking, cells incubated overnight with 0.5 g͞ml H1 DNP--206 were stimulated with antigen, 0.1-100 ng͞ml DNP 21 human serum albumin (HSA) (a gift from Teruko Ishizaka, La Jolla Institute for Allergy and Immunology, San Diego), unless otherwise noted. For monovalent hapten inhibition, DNPlysine (Sigma) or trinitrophenyl (TNP) glutamate (Research Organics) was used in conjunction with anti-DNP or anti-TNP IgEs, respectively.
Flow Cytometry. For measurement of FcRI and c-Kit, BMCMC were incubated first with 10 g͞ml 2.4G2 monoclonal antibody (BD Pharmingen) at 4°C for 10 min, then with 5 g͞ml H1 DNP--206 for 50 min, and then with FITC-conjugated antimouse IgE (BD Pharmingen) and phycoerythrin-conjugated anti-c-Kit monoclonal antibody (BD Pharmingen) for another 30 min. To monitor apoptosis, cells were incubated with 1 g͞ml FITC-labeled annexin V (Clontech) and 2.5 g͞ml propidium iodide (Clontech) at room temperature for 20 min in the dark. Flow cytometric analysis of the stained cells was performed with FACScan or FACSCalibur (Becton Dickinson) equipped with CELLQUEST software.
Measurements of Histamine, Leukotrienes, and Cytokines. Amounts of histamine in BMCMC or in culture supernatants from BM-CMC that had been incubated with IgE in the absence of IL-3 were measured as described (18) . Leukotrienes C 4 ͞D 4 ͞E 4 released into culture supernatants were quantified by radioimmunoassays by using a commercial kit (Amersham Pharmacia Biotech). Supernatants of BMCMC that had been incubated with IgE in the absence of IL-3 were measured by ELISA for IL-2, IL-6, and tumor necrosis factor (TNF)-␣ [BD Pharmingen or Endogen (Cambridge, MA)].
Immunoblotting Analysis and Antibodies. Mast cells were lysed in 1% Nonidet P-40-containing lysis buffer (20 mM Tris⅐HCl, pH 8.0͞0.15 M NaCl͞1 mM EDTA͞1 mM sodium orthovanadate͞1 mM phenylmethylsulfonyl f luoride͞10 g/ml aprotinin͞10 g/ml leupeptin͞25 M p-nitrophenyl pЈ-guanidinobenzoate͞1 M pepstatin͞0.1% sodium azide). Cell lysates were analyzed by SDS͞PAGE followed by immunoblotting. Antibodies used for probing were anti-phospho-p44͞42 MAPK (Thr-202͞Tyr-204), anti-phospho-p38 MAPK (Thr-180͞Tyr-182), anti-phospho-Akt (Ser-473) (all from Cell Signaling Technology, Beverly, MA), and anti-phosphotyrosine monoclonal antibody 4G10 (Upstate Biotechnology, Lake Placid, NY). Stripped membranes were reprobed with anti-extracellular signal-regulated kinase (ERK) (Zymed), anti-p38 (Santa Cruz Biotechnology), and anti-Akt (Santa Cruz Biotechnology), respectively. Proteins reactive with primary antibody were visualized with a horseradish peroxidaseconjugated secondary antibody and enhanced chemiluminescence reagents (NEN Life Science Products).
Transcription Assays. A luciferase reporter construct, the human TNF-␣ (-200)͞Luc, was described previously (19) . Mast cells (1.5 ϫ 10 7 ) were transfected with 5-10 g of reporter plasmid by electroporation at 400 V and 950 F by using a Gene Pulser II apparatus (Bio-Rad). Transfected cells were incubated with or without 10 g͞ml IgE for 8 h before cell harvest. Cells were lysed in 0.2% Triton X-100 in 100 mM potassium phosphate buffer, pH 7.8͞1 mM DTT. Luminescence of cleared lysates was measured after the addition of luciferin solution by using a Monolight 2010 luminometer (Analytical Luminescence Laboratory, San Diego).
Time-Resolved Phosphorescence Anisotropy Measurements. IgEs were derivatized with erythrosin (Er) isothiocyanate (Molecular Probes) as previously described (20, 21) . Before use, all dyederivatized proteins were centrifuged at 130,000 ϫ g for 10 min in an Airfuge (Beckman Instruments) to remove any protein aggregates formed during storage. RBL-2H3 rat mast cells were incubated with phosphorescent protein conjugates by using the indicated IgE concentration at 4°C for 1 h. Before phosphorescence measurements, cells were deoxygenated to eliminate phosphorescence quenching by O 2 . Experiments were performed by using methods previously described (20, 21) as adapted for RBL-2H3 cells. Phosphorescence from deoxygenated cell samples was excited by 532-nm pulses from a neodymium yttrium aluminum garnet (Nd:YAG) laser. Polarized phosphorescence parallel [I ʈ (t)] and perpendicular [I Ќ (t)] to the excitation light was analyzed to yield a phosphorescence intensity function
. Anisotropy data were analyzed according to a single average exponential decay model r(t) ϭ r ϱ ϩ (r 0 Ϫ r ϱ )exp(Ϫt͞), which yielded the initial anisotropy value r 0 , the limiting anisotropy value r ϱ , and the rotational correlation time .
Hybridoma Transplantation. Hybridoma cells (2 ϫ 10 6 ) were injected into the peritoneal cavity of 8-to 10-week-old CAF1͞J female mice. Two weeks later, mice were killed, and various tissues were removed and fixed in Carnoy's fixative followed by 1% alcian blue͞eosin Y staining. Mast cell numbers were counted by a scientist who was not informed of the sample identity. 
Results and Discussion

Different IgEs Exhibit a Wide Spectrum of Cytokine-Producing Ability.
To resolve the apparent discrepancies reported for the antiapoptotic mechanisms of monomeric IgEs (5, 6), we first examined the ability of various IgEs to induce cytokine production by mouse BMCMC. Consistent with our previous results (5), H1 DNP--206 (three lots tested) at 5 g͞ml induced no detectable secretion of IL-6 (Fig. 1A) , IL-2, or tumor necrosis factor (TNF)-␣ (data not shown) during a 6-to 8-h incubation. Similarly, monoclonal anti-dansyl antibody 27-74 and antitrinitrophenyl (TNP) IgE antibodies IgE-3 and C48-2 exhibited little or no cytokine-producing ability. In contrast, substantial amounts of cytokines were secreted from BMCMC treated with H1 DNP--26 (two lots tested), SPE-7 (three lots tested), and C38-2 IgE.
We then devised a sensitive method to investigate whether the cytokines secreted from BMCMC treated with SPE-7 IgE could support survival of mast cells in an autocrine manner. FcRI ␣ Ϫ/Ϫ BMCMC (which cannot respond directly to effects of IgE mediated via FcRI) and WT BMCMC were mixed at various ratios and incubated with 10 g͞ml SPE-7 or H1 DNP--206 IgE in the absence of growth factors for 3 days. When WT BMCMC were included in the cultures with SPE-7, significantly increased survival of the mixed populations was observed compared with the survival expected if IgE enhanced the survival of WT, but not FcRI ␣ Ϫ/Ϫ , BMCMC (Fig. 1B Left) . In contrast, H1 DNP--206 IgE did not enhance the survival of FcRI ␣ Ϫ/Ϫ BMCMC in the mixed populations (Fig. 1B Right) . These results are consistent with the hypothesis that the cytokine(s) secreted from SPE-7 IgE-treated, but not H1 DNP--206 IgE-treated, WT BMCMC support the survival of both WT and FcRI ␣ Ϫ/Ϫ BMCMC. We designate those IgEs that can induce significant cytokine secretion, such as SPE-7, H1 DNP--26, and C38-2 ( Fig. 1 A) , as HC. We designate those IgEs that do not induce significant amounts of cytokine secretion, including H1 DNP--206, 27-74, IgE-3, and C48-2, as PC.
As shown in Fig. 1C , the antiapoptotic potency of H1 DNP--206, H1 DNP--26, and SPE-7 IgEs exhibited the same rank order as their ability to induce cytokine secretion (Fig. 1 A) : SPE-7 Ͼ H1 DNP--26 Ͼ H1 DNP--206. However, even the least cytokinergic IgE (i.e., H1 DNP--206) was able to enhance the survival of WT BMCMC on IL-3 withdrawal (Fig. 1C) . The same rank order in the IgEs' ability to induce IL-6 secretion or enhance survival was observed in BMCMC that were tested in serum-free medium (data not shown).
HC IgEs Efficiently Induce Biological Effects in Mast Cells.
To investigate the molecular basis for the different biological effects of the various IgE species, we examined the effects of IgE binding on several known consequences of FcRI aggregation (9, 10). SPE-7 IgE induced a dramatic increase in BMCMC histamine content ( Fig. 2A) , histamine release ( Fig. 2 B and C) , leukotriene release (Fig. 2D), FcRI internalization (Fig. 2E) , and DNA synthesis (Fig. 2F) . In contrast, H1 DNP--206 IgE failed to induce detectable histamine release, FcRI internalization, or DNA synthesis, although it did induce a slight increase in histamine content and leukotriene release.
We also noticed subtle differences in the degranulation induced by SPE-7 binding alone vs. FcRI aggregation elicited by sensitization with H1 DNP--206 IgE followed by stimulation with the antigen DNP 21 HSA (Fig. 2C) . First, the initial rate of degranulation (during 5 min of stimulation) was approximately three times faster with IgE͞antigen stimulation than with SPE-7 IgE binding. Second, there was a short lag time (from 1 to 5 min, depending on the experiment) before degranulation with SPE-7 IgE binding, but not with IgE͞antigen stimulation.
These observations suggest that IgEs, especially HC IgEs, can induce mast cell activation by a mechanism very similar to that induced by IgE͞antigen-dependent FcRI aggregation. To test this possibility further, we examined the effects of low-level FcRI aggregation as induced by the addition of low concentrations of known specific antigen on mast cell survival. Typically, FcRI aggregation with IgE and antigen (Fig. 2C ) includes a step of washing unbound IgE off the mast cells before the incubation with antigen. However (apparently depending on the details of the experiment), this protocol for inducing FcRI aggregation has been reported to induce either enhanced or reduced mast cell proliferation (10) . Therefore, in this experiment, we elected to add low concentrations (1-10 ng͞ml) of the antigen DNP 21 HSA to growth factor-depleted BMCMC cultures in the presence of 5 g͞ml IgE. As shown previously (6), survival induced by SPE-7 IgE was not further enhanced by the presence of the antigen. In contrast, the antigen did enhance the survival effects of H1 DNP--206 and H1 DNP--26 IgEs in a dose-dependent manner (Fig. 2G) .
HC IgEs Efficiently Induce Intracellular Signaling Events.
HC IgEs induced tyrosine phosphorylation of several proteins and activation of MAPKs (ERK1, ERK2, and p38) and Akt (Fig. 6 , which is published as supporting information on the PNAS web site, www.pnas.org). In contrast, PC IgEs induced little or no activation of any of these events. HC IgEs also induced higher levels of transcriptional activity from the tumor necrosis factor (TNF)-␣ promoter than did PC IgEs (Fig. 7 , which is published as supporting information on the PNAS web site).
As expected, incubation of BMCMC with low concentrations of DNP 21 HSA in the presence of PC IgEs induced activation events such as tyrosine phosphorylation, MAPK activation, and cytokine production (data not shown). These results, together with those shown in Fig. 2 , are consistent with the hypothesis that PC or HC IgEs, or PC IgEs plus low concentrations of antigen, all can induce FcRI aggregation, but of varying magnitude and kinetics and, therefore, with varying biological consequences.
Evidence That Binding of IgE Induces Aggregation of FcRI. The above data collectively suggest that FcRI bound by IgE, particularly HC IgE, is aggregated in a manner that is similar to FcRI aggregation induced by IgE and antigen. To address this issue more directly, we measured time-resolved phosphorescence anisotropies for Er-conjugated HC and PC IgEs bound to FcRI on mast cell surfaces. Phosphorescence anisotropy quantifies, in the nano-to microsecond range, motions of phosphorescent dye-labeled membrane proteins, thus assessing the size and rigidity of the membrane structures containing these proteins. Table 1 compares the phosphorescence anisotropy parameters of Er-conjugated SPE-7 IgE with those of H1 DNP--206 IgE. The initial anisotropy r 0 represents the degree of orientational order exhibited by all excited-state Er chromophores immediately, i.e., Ͻ1 s, after the excitation laser pulse. Thus, r 0 reflects the average anisotropy of all molecules in the sample. The fact that the anisotropies of both Er IgEs increased over time from their initial values (r 0 ) at time 0 to larger limiting anisotropy values (r ϱ ) later may suggest that these IgEs induce spontaneous receptor aggregation. Rising anisotropies typically occur when chromophores with long phosphorescence lifetimes also exhibit large anisotropies. Substantial receptor aggregation would be expected to produce this effect, because Ers on IgEs within the largest receptor aggregates would also have the least accessibility to solution oxygen and, hence, the longest phosphorescence lifetimes. Another important finding is that the initial anisotropy (r 0 ) for the HC IgE was substantially higher than that for the PC IgE. This difference indicates that the average HC IgE molecule is more rigid on the submicrosecond time scale than is the PC IgE, as might be a consequence of more extensive spontaneous receptor aggregation by FcRI-binding HC IgE.
IgE-Mediated Survival and Cytokine-Producing Effects Are Inhibited
by Monovalent Hapten. We next investigated the effect of monovalent hapten, which can disengage IgE͞antigen-mediated aggregation of FcRI (22), on IgE-induced cytokine production and survival. Growth factor-depleted BMCMC were incubated with SPE-7 or H1 DNP--26 IgE in the presence of the hapten DNP-lysine. Hapten inhibited IgE-induced IL-6 secretion in a dose-dependent manner (Fig. 3A) , with an IC 50 of Ϸ2 M. In contrast, IL-6 secretion induced by stem cell factor (23) was not affected by DNP-lysine (data not shown). DNP-lysine also inhibited IgE-induced survival (Fig. 3B) . In control experiments, DNP-lysine influenced neither IL-6 secretion induced by C38-2 (Fig. 3A) nor the survival effect elicited by 27-74 (Fig. 3B) . Using HC IgE with a different specificity, C38-2, and a corresponding hapten, trinitrophenyl (TNP) glutamate, we again showed that hapten inhibited IgE-induced IL-6 production and survival in a dose-dependent manner (data not shown). Hapten also inhibited HC IgE-induced, but not stem cell factor-induced, activation of MAPKs and Akt (Fig. 3C) , as well as FcRI internalization (data not shown), but it did not affect the ability of IgE to bind to FcRI (data not shown). DNP-lysine treatment markedly reduced both initial and limiting anisotropies for both SPE-7 and H1 DNP--206 IgEs (data not shown). These results indicate that monovalent hapten-bound IgE cannot assume a ligand͞receptor configuration that allows FcRI aggregation.
IgE-Mediated Survival and Cytokine-Producing Effects Depend on Syk.
Degranulation and other activation events elicited by FcRI aggregation with IgE and antigen are totally abrogated by deficiency of the protein tyrosine kinase Syk (24, 25) . Strikingly, syk Ϫ/Ϫ BMCMC failed to produce and secrete cytokines or to exhibit antiapoptotic effects in response to either HC or PC IgEs (Fig. 4) . In contrast, syk (Fig. 7) . These results indicate that the survival effect induced by HC IgE can be observed in the presence of much higher concentrations of PC IgE. Second, a mixture of several monoclonal IgEs exhibited a survival effect that was approximately an average of those of the individual IgEs (Fig. 7) .
Third, we tested whether IgE binding can influence mast cell numbers in vivo. We transplanted IgE-or IgG2b-secreting hybridomas into the peritoneal cavity of CAF1͞J mice, and mast cells in various tissues were enumerated two weeks after transplantation. Mast cell numbers in the stomach mucosa of the mice harboring H1 DNP--206 or H1 DNP--26 IgE hybridomas (11) were higher than in those harboring an anti-DNP IgG2b hybridoma or in those injected with PBS (Fig. 5A) , and mice harboring H1 DNP--26 IgE hybridoma cells had more stomach mucosal mast cells than those harboring H1 DNP--206 IgE hybridoma cells. Similar findings were observed in the mucosa of the jejunum. However, in two of three experiments, there were no significant differences in the mast cell numbers in other tissues in which mast cell turnover is not as rapid as in the gastrointestinal mucosa (26), such as back or ear skin or the muscularis propria of the stomach. Importantly, there was a significant correlation between mast cell numbers in the mucosa of the stomach or jejunum and levels of serum IgE, but not IgG2b (Fig.  5B and data not shown) . These experiments do not define the mechanism(s) linking elevated levels of circulating IgE with increased numbers of mucosal mast cells in vivo. However, the data are consistent with the hypothesis that IgE can enhance mast cell development and͞or survival in vivo.
Conclusions
We have demonstrated that binding of various IgEs by mast cells can induce a spectrum of activation events in the absence of antigen for which the IgE is known to have specificity. HC IgEs can promote mast cell survival more strongly than PC IgEs, presumably in part by inducing secretion of cytokines, whereas PC IgEs also can enhance mast cell survival, but less strongly and by an apparently cytokine-independent mechanism. However, the simplest (albeit not the only) explanation for all of our data is that PC and HC IgEs can induce a spectrum of FcRI aggregation, associated with a corresponding spectrum of effects on mast cell signaling, survival, FcRI internalization, and mediator͞cytokine release. Whether ''monomeric'' IgE can enhance mast cell survival and͞or mediator secretion by a mechanism that involves FcRI aggregation (as our data strongly suggest) or by some other process, the structural features that account for the functional differences between HC and PC IgEs remain to be identified.
Potentially related to this issue, a recent study (27) showed that the SPE-7 antibody can adopt different antigen binding site conformations before antigen binding and that binding of different antigens can induce isomerization of the binding site, leading to high-affinity complexes with a deep or narrow binding site. Given this and related studies (28) and the results of our experiments with monovalent hapten (Fig. 3) , one could hypothesize that IgEs can induce FcRI aggregation in the absence of the antigen for which those IgEs are known to have specificity when the Fab fragment of an FcRI-bound IgE molecule interacts with a neighboring FcRI-bound IgE directly or indirectly via a third molecule whose epitopes are recognized by neighboring IgEs. For example, in the case of anti-DNP IgE, a cross-reactive epitope within IgE or another molecule might be bound by anti-DNP IgE. Regardless of the nature of the mechanism(s) by which IgE might enhance mast cell survival and͞or mediator secretion in the absence of the antigens for which that IgE is known to have specificity, our findings offer a perspective on the well established and highly positive correlation between serum levels of IgE and the prevalence of asthma and other allergic diseases (29) . In addition to enhancing antigendependent mast cell activation and mediator͞cytokine secretion by increasing surface expression of FcRI (3, 4) , high levels of IgE also may promote mast cell activation and survival independently of the presence of antigens for which the IgE is known to have specificity. One may even speculate that the severity of allergic disorders in some individuals may reflect a predisposition to secrete one type of IgE (HC) over others (PC).
